quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 16, 2026

NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI

View original at globenewswire.com
NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI News Summary: NVIDIA Nemotron 3 omni-understanding models power AI agents delivering natural conversations, complex reasoning and advanced visual capabilities.NVIDIA Isaac GR00T N1.7, NVIDIA Alpamayo 1.5 and NVIDIA Cosmos 3…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Cosmos 3 is the first world foundation model to unify synthetic world generation, physical AI reasoning and action simulation

    60% confidence
  • Isaac GR00T N1.7 is now commercially viable for real-world deployment

    60% confidence
  • Open source AI has become a global force for innovation

    60% confidence
  • NVIDIA open model families extend intelligence beyond language, enabling developers worldwide to build intelligent agents and power breakthroughs across digital and physical industries

    60% confidence
  • nvQSP delivered up to 77x faster performance compared with traditional single-threaded CPU simulations

    60% confidence
  • Open source AI has become a global force for innovation

    60% confidence
  • From biology and scientific discovery to robotics and autonomous machines, NVIDIA open model families extend intelligence beyond language, enabling developers worldwide to build intelligent agents and power breakthroughs across digital and physical industries

    60% confidence
  • NVIDIA is the world leader in AI and accelerated computing

    60% confidence
  • nvQSP delivered up to 77x faster performance compared with traditional single-threaded CPU simulations in benchmark tests

    60% confidence
  • From biology and scientific discovery to robotics and autonomous machines, NVIDIA open model families extend intelligence beyond language, enabling developers worldwide to build intelligent agents and power breakthroughs across digital and physical industries

    60% confidence
  • Cosmos 3 is the first world foundation model to unify synthetic world generation, physical AI reasoning and action simulation

    60% confidence
  • GR00T N2 currently ranks No. 1 on MolmoSpaces and RoboArena for generalist robot policies

    60% confidence
  • GR00T N2 helps robots succeed at new tasks in new environments more than twice as often as leading VLA models

    60% confidence
  • GR00T N2 will be available by the end of the year

    60% confidence
  • Nemotron 3 Ultra delivers frontier-level intelligence with 5x throughput efficiency with the NVFP4 format on the NVIDIA Blackwell platform

    60% confidence
  • Kosmos is used by more than 50,000 researchers and performs hundreds of research tasks in parallel, compressing months of research into a day

    60% confidence
  • Open source AI has become a global force for innovation. From biology and scientific discovery to robotics and autonomous machines, NVIDIA open model families extend intelligence beyond language, enabling developers worldwide to build intelligent agents and power breakthroughs across digital and physical industries.

    60% confidence
  • Nemotron 3 Ultra delivers frontier-level intelligence with 5x throughput efficiency with the NVFP4 format on the NVIDIA Blackwell platform

    60% confidence
  • GR00T N2 helps robots succeed at new tasks in new environments more than twice as often as leading VLA models

    60% confidence
  • Nemotron 3 Ultra delivers frontier-level intelligence with 5x throughput efficiency with NVFP4 format on Blackwell platform

    60% confidence
  • NVIDIA Cosmos 3 is expected to come soon

    60% confidence
  • NVIDIA collaborated with EMBL's European Bioinformatics Institute, Google DeepMind and Seoul National University to calculate about 30 million protein complex predictions and add 1.7 million high-confidence predictions to the AlphaFold database

    60% confidence
  • GR00T N2 currently ranks No. 1 on MolmoSpaces and RoboArena for generalist robot policies

    60% confidence
  • NVIDIA open model families extend intelligence beyond language, enabling developers worldwide to build intelligent agents and power breakthroughs across digital and physical industries

    60% confidence
  • nvQSP delivered up to 77x faster performance compared with traditional single-threaded CPU simulations in benchmark tests

    60% confidence
  • nvQSP delivered up to 77x faster performance compared with traditional single-threaded CPU simulations in benchmark tests

    60% confidence
  • Nemotron 3 Ultra delivers 5x throughput efficiency with NVFP4 format on Blackwell platform

    60% confidence
  • nvQSP delivered up to 77x faster performance compared with traditional single-threaded CPU simulations

    60% confidence
  • Open source AI has become a global force for innovation

    60% confidence
  • Kosmos autonomous AI scientist is used by more than 50,000 researchers and performs hundreds of research tasks in parallel, compressing months of research into a day

    60% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI — Source | Via News | pt.VIA.NEWS